JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

Because they touch so many parts of this economy, banks’ quarterly reports can reveal a lot.

Can this ASX 200 juggernaut go higher? The post JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in ...

Europe is “losing” the fight for economic supremacy against its main rivals China and the US, and faces a drought of globally ...

Wall Street analysts are often criticized for being preternaturally upbeat. Buy ratings for top companies are abundant, and ...

Here are four stocks from the J.P. Morgan's Analyst Focus List for cautious investors consider for the second half of 2025.

Molina Healthcare, Inc. (NYSE:MOH) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 7, JP Morgan ...

Investing.com -- JP Morgan initiated coverage of Circle with an Underweight rating and a price target of $80, arguing the ...

On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...